Chemical Compound

Aprepitant

CAS Registry Number 170729-80-3
Aprepitant chemical structure
Primary Record

Aprepitant

In stock
7,788 g
Purity
98.3 %
CAS
170729-80-3

Compound Identifiers & Properties

CAS
170729-80-3
PubChem CID
135413536
SMILES
C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F
Canonical SMILES
C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

Names & Synonyms

  • Aprepitant
  • Emend
  • 170729-80-3
  • Cinvanti
  • Aponvie
  • aprepitantum
  • Agrepitant
  • Apripetant
  • eMende
  • MK-869
  • Aprepitant [USAN]
  • Aprepitant CRS
  • Emend (TN)
  • Cinvanti (TN)
  • aprepitant, form I
  • Aponvie (TN)
  • MK-0869
  • aprepitant, form II
  • Aprepitant Impurity I
  • Aprepitant (Standard)
  • AC1OCFCG
  • 1NF15YR6UY
  • ONO-7436
  • APREPITANT [MI]
  • RefChem:57104
  • UNII-1NF15YR6UY
  • Fosaprepitant Impurity C
  • APREPITANT [INN]
  • APREPITANT [JAN]
  • Aprepitant(MK-0869)
  • C23H21F7N4O3
  • CHEMBL1471
  • APREPITANT [VANDF]
  • DTXSID3049047
  • D0GU4K
  • Aprepitant (MK-0869)
  • Aprepitant [USAN:INN:JAN]
  • APREPITANT [MART.]
  • ATALOFNDEOCMKK-OITMNORJSA-N
  • APREPITANT [USP-RS]
  • APREPITANT [WHO-DD]
  • MFCD08277635
  • Aprepitant (JAN/USP/INN)
  • Aprepitant Related Compound A
  • cc-310
  • MLS006011068
  • Aprepitant (JAN/USAN/INN)
  • APREPITANT [EMA EPAR]
  • L-754030
  • NSC-748825
  • SCHEMBL264924
  • SCHEMBL280611
  • CHEBI:499361
  • MK 869
  • Aprepitant - Bio-X trade mark
  • DTXCID801021794
  • GTPL3490
  • orb1307556
  • SCHEMBL7117513
  • APREPITANT [ORANGE BOOK]
  • CTK4D3687
  • MK 0869
  • A04AD12
  • AOB6779
  • APREPITANT [EP MONOGRAPH]
  • EX-A212
  • MK0869
  • APREPITANT [USP MONOGRAPH]
  • GLXC-05008
  • HMS2090N12
  • HMS3714E16
  • HMS3884G05
  • MK869
  • ONO 7436
  • Tox21_113595
  • ABP000600
  • BDBM50220136
  • EBC-11285
  • EBC-27288
  • HY-10052R
  • MFCD12912491
  • MK0517
  • NSC748825
  • s1189
  • ZINC27428713
  • AKOS015895498
  • AKOS015969344
  • Tox21_113595_1
  • ACN-037208
  • BCP9000312
  • C23-H21-F7-N4-O3
  • CCG-220747
  • CCG-264854
  • CID6918365
  • CS-0487
  • DB00673
  • FA17962
  • MK-0517
  • NSC 748825
  • RL02193
  • L 754030
  • L-754,030
  • NCGC00181785-01
  • NCGC00181785-03
  • NCGC00181785-11
  • NCGC00181785-12
  • NCGC00344566-01
  • AS-14638
  • BA164216
  • HY-10052
  • L982
  • SMR002530053
  • SY027654
  • Aprepitant (MK-0869, L-754030)?
  • A3135
  • Aprepitant,MK-0869, L-754030, Emend
  • CAS-170729-80-3
  • FT-0658107
  • MK-869, L-754030, Emend, Aprepitant
  • 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
  • J1.059.639D
  • A10083
  • A24972
  • C21555
  • D02968
  • EN300-761455
  • SBI-0654102.0001
  • W-5373
  • AB01274775-01
  • AB01274775_02
  • AB01275535-01
  • 729A803
  • L754030
  • SR-05000001531
  • 5-[2(R)-[1(R)-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]-3(S)-(4-FLUOROPHENYL)MORPHOLIN-4-YLMETHYL]-3,4-DIHYDRO-2H-1,2,4-TRIAZOL-3-ONE
  • I06-1151
  • L754,030
  • SR-05000001531-1
  • BRD-K52827117-001-01-6
  • L 754,030
  • 5-[[(2R,3S)-2-[(1R)-1-[3,5-BIS(Trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one
  • Z2937147473
  • B2692-461949
  • 3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one
  • 3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one
  • 321125-94-4
  • 3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-
  • 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-3(2H)-one
  • 5-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,3-dihydro-1H-1,2,4-triazol-3-one
  • Aprepitant, United States Pharmacopeia (USP) Reference Standard
  • 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one
  • 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one
  • 3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-4,5-dihydro-1H-1,2,4-triazol-5-one
  • 3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,4-dihydro-
  • 5-[(2R,3S)-2-[(R)-1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy]-3-(4-fluoro-phenyl)-morpholin-4-ylmethyl]-2,4-dihydro-[1,2,4]triazol-3-one
  • 5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
  • 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
  • (2R)-3alpha-(4-Fluorophenyl)-4-[5(4H)-oxo-1H-1,2,4-triazole-3-ylmethyl]-2alpha-[[(R)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl]oxy]morpholine
  • 1148113-53-4
  • 221350-96-5
  • 3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-4,5-dihydro-1H-1,2,4-triazol-5-one
  • 3-(((2R,3S)-3-(P-FLUOROPHENYL)-2-(((.ALPHA.R)-.ALPHA.-METHYL-3,5-BIS(TRIFLUOROMETHYL)BENZYL)OXY)MORPHOLINO)METHYL)-.DELTA.(SUP 2)-1,2,4-TRIAZOLIN-5-ONE.
  • 3-[((2R,5-bis(trifluoromethyl)benzyl]oxy}morpholino)methyl]-.delta.2-1,2,4-triazolin-5-one
  • 3-[[(2R)-2alpha-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3alpha-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazole-5(4H)-one
  • 3-[[(2R)-2alpha-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3alpha-(4-fluorophenyl)morpholino]methyl]-4,5-dihydro-1H-1,2,4-triazole-5-one
  • 3-[[(2R)-2alpha-[[(R)-alpha-Methyl-3,5-di(trifluoromethyl)benzyl]oxy]-3alpha-(4-fluorophenyl)morpholino]methyl]-4,5-dihydro-1H-1,2,4-triazole-5-one
  • 3-[[(2R,3S)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazole-5(4H)-one
  • 3-[[(2R,3S)-2-[[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethyl]oxy]-3-(4-fluorophenyl)morpholine-4-yl]methyl]-1H-1,2,4-triazole-5(4H)-one
  • 3-[[(2R,3S)-2-[[(alphaR)-alpha-Methyl-3,5-bis(trifluoromethyl)benzyl]oxy]-3-(4-fluorophenyl)morpholine-4-yl]methyl]-1H-1,2,4-triazole-5(4H)-one
  • 3-[[(2R,3S)-3-(4-Fluorophenyl)-2-[[(R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]oxy]morpholino]methyl]-1H-1,2,4-triazole-5(4H)-one
  • 3-[[2alpha-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3alpha-(4-fluorophenyl)morpholine-4-yl]methyl]-1H-1,2,4-triazole-5(4H)-one
  • 3-[2-{1-[3,5-di(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)-1,4-oxazinan-4-ylmethyl]-4,5-dihydro-1H-1,2,4-triazol-5-one
  • 3h-1,2,4-triazol-3-ona, 5-[[(2r,3s)-2-[(1r)-1-[3,5-bis(trifluorometil)fenil]etoxi]-3-(4-fluorofenil)-4-morfolinil]metil]-1,2-dihidro-
  • 3H-1,2,4-Triazol-3-one, 5-((2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-, (2R-(2alpha(R*),3alpha))-
  • 3H-1,2,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-, rel-
  • 3H-1,2,4-Triazol-3-one,5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-,rel-
  • 3H-1,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-
  • 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-3H-1,2,4-Triazol-3-one
  • 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-1,2-dihydro-1,2,4-triazol-3-one
  • 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
  • 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-2H-1,2,4-triazol-3(4H)-one
  • 5-[[(2~{R},3~{S})-2-[(1~{R})-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
  • 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol- 3-one
  • 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one; 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one; Aprepitant; Emend; L 754030; MK 0869; MK 869; ONO 7436; 3H-1,2,4-Triazol-3-one, 5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-, [2R-[2alpha(R*),3alpha]]-
  • 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1,2-dihydro-3H-1,2,4-triazole-3-one
  • 5-[[(2R,3S)-2-[(R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-3(2H)-one
  • 5-[[2alpha-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3alpha-(4-fluorophenyl)morpholino]methyl]-2,4-dihydro-3H-1,2,4-triazole-3-one
  • 5-[2-[1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy]-3-(4-fluoro-phenyl)-morpholin-4-ylmethyl]-2,4-dihydro-[1,2,4]triazol-3-one
  • 5-{[(2R,3S)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1,2-dihydro-3H-1,2,4-triazol-3-one
  • 677-636-6